Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

Market Cap (11-Sep) $32,321,630 (199th)	Close (30-Jun) $0.091 0 (0%)	Volume (30-Jun) 50,159,971	Shortsold (7-Sep) 1,913,247 (0.36%) (346th)
52w High $0.460	52w Low $0.054	P/E 13.30	EPS -0.32

Short Interest

ASIC data, 7 Sep 2026

% Shorted

0.36% 0.00

vs 0.36% prior report

Most Shorted Rank

346th

of 692 shorted ASX stocks

Peak Short

8.10%

Aug 2023

Days to Cover

0.8

at 50d avg vol

View full short position history →

	Subject
	IMU IMU Ann: Change of Director's Interest Notice
	1 (current) 2 3
	IMU IMU Ann: HER-Vaxx induced antibodies correlated with tumour reduction
	IMU IMU Ann: Imugene PD1-Vaxx patent extended to 2040
	IMU IMU Ann: Initial Director's Interest Notice
	IMU IMU Ann: Imugene Appoints Kim Drapkin as Non-Executive Director
	IMU IMU Ann: Imugene Advances VAXINIA MAST Trial to Next IV Cohorts
	IMU IMU Ann: Imugene doses first combination patient in PD1-Vaxx trial
	IMU IMU Ann: Imugene Investor Webinar - FDA IND Clearance for onCARlytics
	IMU IMU Ann: FDA clears Imugene IND for onCARlytics first-in-class study
	IMU IMU Ann: onCARlytics with ARTEMIS T cells show anti-tumour activity
	IMU IMU Ann: onCARlytics with Artemis T cells abstract presented at ASGCT
	IMU IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMU IMU Ann: Imugene receives $12.6m R&D tax refund
	IMU IMU Ann: Imugene Images and Follows CHECKVacc in TNBC Patients
	IMU IMU Ann: First patients dosed in IT & IV cohort 3 of VAXINIA trial
	IMU IMU Ann: Imugene Presentation to NWR Healthcare Conference
	IMU IMU Ann: Imugene to present at NWR Virtual Healthcare Conference
	IMU IMU Ann: Imugene Corporate Presentation
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Change of Registered Office
	IMU IMU Ann: First Patients Dosed in Combination Study of VAXINIA
	IMU IMU Ann: Imugene appoints CFO Mike Tonroe as Company Secretary
	IMU IMU Ann: Half Yearly Report and Accounts
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Imugene PD1-Vaxx Immunotherapy Patent Granted in the US
	IMU IMU Ann: Imugene VAXINIA trial advances to Combination Cohort
	IMU IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMU IMU Ann: HER-Vaxx and CF33 Platforms Featured at ASCO Symposium
	IMU IMU Ann: Imugene Presentation to the JP Morgan Healthcare Conference
	IMU IMU Ann: Imugene Receives Vaxinia Ethics Approval in Australia
	IMU IMU Ann: Letter to Shareholders
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Ceasing to be a substantial holder
	IMU IMU Ann: Ceasing to be a substantial holder
	IMU IMU Ann: Change of Director's Interest Notice x6
	IMU IMU Ann: Notification of cessation of securities - IMU
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Imugene HER-Vaxx and CF33 Platforms To Feature at ASCO
	IMU IMU Ann: Imugene to Present at J.P. Morgan Healthcare Conference
	IMU IMU Ann: CHECKVacc Data Presented at the 2022 SABC Symposium
	IMU IMU Ann: Appendix 3H
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Appendix 2A
	IMU IMU Ann: First Patient Dosed in VAXINIA Intravenous Cohort 2
	IMU IMU Ann: Positive New HER-Vaxx HERIZON Data Presented at ESMO Asia
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
11-Sep	$0.05	3,206,030	0.00 (6.90%)
10-Sep	$0.06	2,370,473	0.00 (7.94%)
09-Sep	$0.06	5,130,624	0.00 (3.08%)
08-Sep	$0.07	1,163,363	0.00 (4.41%)
07-Sep	$0.07	1,506,851	0.00 (1.45%)
04-Sep	$0.07	1,360,438	+0.00 (4.55%)
03-Sep	$0.07	1,064,652	0.00 (2.94%)
02-Sep	$0.07	1,490,620	0.00 (0.00%)
01-Sep	$0.07	1,822,847	0.00 (0.00%)
31-Aug	$0.07	1,640,971	0.00 (2.86%)
28-Aug	$0.07	1,459,276	0.00 (1.41%)
27-Aug	$0.07	2,515,348	0.00 (0.00%)
26-Aug	$0.07	2,965,581	0.00 (2.74%)
25-Aug	$0.07	6,167,979	-0.01 (7.59%)
24-Aug	$0.08	2,485,415	0.00 (3.66%)
1 up, 11 down, and 3 flat days

Imugene Health Care
Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy